市場調查報告書
商品編碼
1464824
生物樣本處理市場:按類型、產品類型、最終用途、應用分類 - 2024-2030 年全球預測Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
生物樣本處理市場規模預計到 2023 年為 186.2 億美元,到 2024 年達到 198.5 億美元,預計到 2030 年將達到 288.8 億美元,複合年成長率為 6.47%。
生物樣本處理是指以維持樣本完整性並最大限度地減少污染和劣化的方式收集、儲存、處理和運輸生物樣本,例如血液、組織和唾液。這個過程對於確保生物學研究、臨床診斷和治療性介入的可靠性至關重要。該過程包括根據生物樣本的獨特要求量身定做的各種協議和程序,例如溫度控制、污染預防以及有關樣本收集和使用的法律和道德合規性。研究與開發 (R&D) 活動的增加,特別是在基因組學、蛋白質組學和個人化醫療領域,增加了對先進樣本處理解決方案的需求,以確保樣本的完整性和真實性。然而,與生物樣本處理相關的嚴格法規是主要企業面臨的重大挑戰。公司遵守政府法規,以在全球範圍內保持永續和敏捷性。此外,自動化和冷凍保存技術的進步徹底改變了生物樣本的處理。自動化系統減少了人為錯誤並提高了通量,而冷凍保存技術的進步則延長了樣品的存活時間並支持長期研究。
主要市場統計 | |
---|---|
基準年[2023] | 186.2億美元 |
預測年份 [2024] | 198.5億美元 |
預測年份 [2030] | 288.8億美元 |
複合年成長率(%) | 6.47% |
擴大採血套件和拭子的使用,以在產品運送過程中保存病毒檢體
在生物樣品處理中,各種產品對於準確、有效率地採集、運輸和分析檢體至關重要。這些重要產品包括血液採集套件,旨在安全有效地採集血液樣本以進行各種診斷。拭子,如鼻拭子、鼻咽拭子和口咽拭子,是用於從特定解剖部位採集檢體的專用工具,特別是在病毒病原體檢測中,為採集細胞或體液進行檢測提供了一種微創採集手段。此外,病毒運輸介質在運輸過程中保存病毒檢體、確保分析前檢體的完整性和活力方面發揮關鍵作用。每件產品均按照嚴格的衛生標準精密設計,以促進準確的診斷和調查,強調生物樣品處理中品質和可靠性的重要性。
最終用途:在醫院中更多地採用生物樣本處理解決方案,以促進主動的健康管理
診斷中心是生物樣本專業測試和分析的重要場所。這些設施對於準確的疾病診斷和醫療決策至關重要。居家照護是一個新興領域,反映了向以患者為中心的醫療模式的更廣泛轉變。在這一領域,諸如家庭檢測套組之類的創新有助於在舒適和私密的家中收集和處理生物樣本,從而促進積極的健康管理。此外,醫院和診所是傳統且重要的生物樣本處理場所。這些機構處於患者照護的第一線,收集、分析和儲存樣本,以滿足從常規篩檢到複雜手術的廣泛臨床需求。
區域洞察
在美洲,生物樣品處理受到嚴格監管,強烈要求遵守 FDA 法規和指南。最近的專利專注於提高樣品處理的準確性和效率。對生物銀行和個人化醫療的投資正在推動該地區對先進樣本處理解決方案的需求。美國客戶優先考慮可靠性和質量,並且對自動化和整合系統越來越感興趣。同時,歐洲、中東和非洲地區擁有嚴格的法規環境,重點關注資料保護和病患隱私,這影響了樣品處理業務。該地區對生物樣本庫和轉化研究的投資正在成長。此外,亞太地區正在經歷市場動態的動態變化,其特點是由於對生物樣本庫的投資增加、生物製藥行業的擴張以及對研發活動的日益重視而導致顯著成長。慢性病的快速增加和對個人化醫療的迫切需求是推動生物樣本處理技術進步的關鍵驅動力。
FPNV定位矩陣
FPNV 定位矩陣對於評估生物樣本處理市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對生物樣本處理市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.生物樣本處理市場的市場規模與預測為何?
2.在生物樣本處理市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.生物樣本處理市場的技術趨勢和法規結構是什麼?
4.生物樣本處理市場主要供應商的市場佔有率為何?
5. 進入生物樣本處理市場的合適型態和策略手段是什麼?
[186 Pages Report] The Biological Sample Handling Market size was estimated at USD 18.62 billion in 2023 and expected to reach USD 19.85 billion in 2024, at a CAGR 6.47% to reach USD 28.88 billion by 2030.
Biological sample handling refers to collecting, storing, processing, and transporting biological materials, such as blood, tissue, saliva, or any other organismal specimen, in a way that preserves the integrity and minimizes contamination or degradation of the sample. This process is crucial for ensuring the reliability of biological research, clinical diagnostics, and therapeutic interventions. It encompasses a wide range of protocols and procedures tailored to the specific requirements of the biological material, including temperature control, contamination prevention, and legal and ethical compliance regarding sample collection and use. An increase in research and development (R&D) activities, especially in genomics, proteomics, and personalized medicine, drives the demand for sophisticated sample-handling solutions to ensure sample integrity and reliability. However, the strict regulations associated with biological sample handling are a significant challenge the key players face. Companies adhere to government regulations to remain sustainable and agile within the global space. Moreover, technological advancements in automation and cryopreservation have revolutionized the handling of biological samples. Automated systems reduce human error and increase throughput, while advances in cryopreservation techniques have extended the viability of samples, thereby supporting longer-term studies.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.62 billion |
Estimated Year [2024] | USD 19.85 billion |
Forecast Year [2030] | USD 28.88 billion |
CAGR (%) | 6.47% |
Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
In biological sample handling, various products are essential for the accurate and efficient collection, transport, and analysis of specimens. Among these critical products are blood collection kits designed to gather blood samples safely and effectively for various diagnostics. Swabs, including nasal swabs, nasopharyngeal swabs, and oropharyngeal swabs, are specialized tools used for the collection of samples from specific anatomical locations, offering a minimally invasive means to acquire cells or fluids for testing, notably in the detection of viral pathogens. Additionally, viral transport media plays a pivotal role in preserving viral samples during transport, ensuring the integrity and viability of the specimens until analysis. Each product is designed with precision and adherence to stringent health standards to facilitate accurate diagnostics and research, highlighting the importance of quality and reliability in biological sample handling.
End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
Diagnostic centers are pivotal venues for specialized testing and analysis of biological samples. These facilities are essential for accurate disease diagnosis and integral to medical decision-making. Homecare represents an emerging segment reflective of a broader shift towards patient-centric healthcare models. In this domain, innovations such as at-home testing kits facilitate individuals' collection and handling of biological samples in the comfort and privacy of their homes, thereby promoting proactive health management. Moreover, hospitals & clinics are traditional and vital settings for biological sample handling. These institutions are at the forefront of patient care, with the collection, analysis, and storage of samples supporting a wide range of clinical needs, from routine check-ups to complex surgeries.
Regional Insights
In the Americas, biological sample handling is highly regulated, strongly emphasizing compliance with FDA regulations and guidelines. Recent patents have focused on improving the accuracy and efficiency of sample processing. Investments in biobanking and personalized medicine have driven the demand for advanced sample-handling solutions in this region. Customers in America prioritize reliability and quality, with a growing interest in automation and integrated systems. On the other hand, in the EMEA, the regulatory environment is stringent, with a focus on data protection and patient privacy impacting sample handling practices. Investments in biobanks and translational research are widespread in the region. Moreover, the Asia-Pacific region is witnessing a dynamic shift in the biological sample handling market, characterized by significant growth due to rising investments in biobanking, an expanding biopharmaceutical sector, and an increasing emphasis on research and development activities. The proliferation of chronic diseases and the urgent need for personalized medicine are significant drivers propelling advancements in biological sample-handling techniques.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biological Sample Handling Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biological Sample Handling Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biological Sample Handling Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biological Sample Handling Market?
3. What are the technology trends and regulatory frameworks in the Biological Sample Handling Market?
4. What is the market share of the leading vendors in the Biological Sample Handling Market?
5. Which modes and strategic moves are suitable for entering the Biological Sample Handling Market?